Table 1

Primary antibodies

Specificity	Clone number	Source	Dilution
α1	TS2/7	Dr F Sanchez-Madrid, Universidad Autónomale, Madrid, Spain	1:15
α2	P1E6	Life Technologies, Paisley, UK	1:1000
α3	P1B5	Becton Dickenson, San Jose, CA, USA	1:1000
α4	P4G9	Biogenesis, Poole, UK	1:1000
α5	BIIG2	Dr C Damsky, University of California, San Francisco, CA, USA	1:100
α6	GOH3	Serotec, Kidlington, Oxford, UK	1:1000
αV	VNR147	Chemicon International, Danvers, MA, USA	1:2000
β1	TS2/16	Dr F Sanchez-Madrid, Universidad Autónomale, Madrid, Spain	1:1000
β2	MHM23	DAKO, Glostrup, Denmark	1:200
β3	Y2/51	DAKO, Glostrup, Denmark	1:200
β4	3E1	Chemicon International, Danvers, MA, USA	1:1000
αVβ5	P1F6	Life Technologies, Paisley, UK	1:1000
β6	E7P6G10P0	Dr D Sheppard, University of California, San Francisco, CA, USA	1:1000